Delivery Order SPE2DB22D2108-SPE2DB23FU4JM
Award Date 8/23/23
Potential Completion Date 8/24/23
Potential Value $3.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,727 to Amerisourcebergen Drug Corporation for the supply of 50 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone replacement drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in mid-July 2023. Amerisourcebergen Corporation is the identified parent company. No subcontractors or set aside designations were indicated. This order...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,275 to Amerisourcebergen Drug Corporation for XYOSTED 75 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the injectable testosterone replacement therapy products to a location in Conshohocken, Pennsylvania by July 13, 2023 in support of DLA procurement programs. Amerisourcebergen Corporation is the identified parent company of Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,240 to Amerisourcebergen Drug Corporation for XYOSTED 100 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the injectable testosterone replacement therapy products to a location in Conshohocken, Pennsylvania by July 10, 2023 to support DLA requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which...
- The Defense Logistics Agency Troop Support Medical awarded a $861.97 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg/0.5 ml auto-injectors of XYOSTED. Performance will take place in Conshohocken, Pennsylvania over July 19-20, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor for this requirement to supply the injectable testosterone medication. No subcontractors or set-aside...
- The Defense Logistics Agency awarded a $6,165.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. The place of performance will be in Conshohocken, Pennsylvania over the period of August 1-2, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling this order to supply the injectable testosterone cypionate product in support of DLA programs. No major...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,508 to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. Performance will occur in Conshohocken, Pennsylvania under a contract scheduled from August 28 through 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order from its corporate office division. No set aside designation or subcontractors...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754.26 firm fixed price delivery order by the Defense Logistics Agency to supply 50mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for performance in Conshohocken, Pennsylvania from August 4-7, 2023. As the prime contractor for delivery order under an unspecified agency-wide contract vehicle, Amerisourcebergen will fulfill the Defense Logistics Agency's requirement for this...
- The Defense Logistics Agency awarded a $306 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561521698 XYOSTED 75 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the 0.5mL auto-injectable testosterone cypionate product to a location in Conshohocken, Pennsylvania by July 18, 2023 to support Defense Logistics Agency requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation,...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $636 to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. Performance will occur in Conshohocken, Pennsylvania over one day in early August 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor to supply the injectable testosterone product to the DLA Troop Support...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $502,860 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a testosterone replacement drug. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in July 2023. The delivery order was issued under the DLA's Pharmaceutical Prime Vendor contract vehicle, which provides pharmaceuticals and...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB23FU4JMDelivery Order
The Defense Logistics Agency awarded a $3,433.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED, a testosterone replacement therapy medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in late August 2023. Amerisourcebergen Corporation is the identified parent company. No subcontractors or set aside designations were indicated. This order is likely part of DLA's pharmaceutical procurement activities in support of military treatment facilities and beneficiary prescription drug programs.
Generated 12/20/23, 11:37 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/23/23 |